tiprankstipranks
Trending News
More News >

Oxford Biomedica Strengthens Leadership with New Board Appointment

Story Highlights
Oxford Biomedica Strengthens Leadership with New Board Appointment

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Oxford BioMedica ( (GB:OXB) ).

Oxford Biomedica announced the appointment of Mr. Colin Bond as an Independent Non-Executive Director of OneSource Specialty Pharma Limited, pending shareholder approval. This appointment reflects OXB’s strategic efforts to strengthen its leadership and expand its influence in the global cell and gene therapy market.

The most recent analyst rating on (GB:OXB) stock is a Buy with a £5.00 price target. To see the full list of analyst forecasts on Oxford BioMedica stock, see the GB:OXB Stock Forecast page.

Spark’s Take on GB:OXB Stock

According to Spark, TipRanks’ AI Analyst, GB:OXB is a Neutral.

Oxford BioMedica’s stock score is driven by its robust revenue growth and strategic expansions, offset by profitability challenges and high leverage. Technical indicators and valuation metrics provide mixed signals, while positive corporate developments support the outlook.

To see Spark’s full report on GB:OXB stock, click here.

More about Oxford BioMedica

OXB (LSE: OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. With 30 years of experience, OXB is a pioneer in viral vectors, collaborating with leading pharmaceutical and biotechnology companies to provide expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. The company offers a range of technologies for viral vector manufacturing and has facilities in the UK, France, and the US.

Average Trading Volume: 210,067

Technical Sentiment Signal: Sell

Current Market Cap: £335.3M

For an in-depth examination of OXB stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1